2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine
CAS : 165125-95-1
Ref. 3D-FB177417
| 1g | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine
Synonymes :
- 2-[6-(4,5-Dihydro-1,3-Oxazol-2-Yl)Pyridin-2-Yl]-4,5-Dihydro-1,3-Oxazole
Description :
2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine (BDP) is a palladium catalyst that can be used in hydrogenation reactions. It has been shown to be a solid catalyst for the hydrogenation of carboxylic acids and ketones. BDP has also been used as an anti-inflammatory drug as it inhibits the production of prostaglandin E2. This compound is made from ethyl diazoacetate and 2,6-dichloropyridine by reaction with copper(II) bromide in a solvent such as ethanol or toluene. The yield of this compound is usually low due to its instability. BDP has been shown to emit light when it is excited at certain wavelengths, which makes it useful for research purposes.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
217.22 g/mol
Formule :
C11H11N3O2
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C11H11N3O2/c1-2-8(10-12-4-6-15-10)14-9(3-1)11-13-5-7-16-11/h1-3H,4-7H2
Code InChI :
InChIKey=YOCRKHKJFCWTHG-UHFFFAOYSA-N
SMILES :
c1cc(C2=NCCO2)nc(C2=NCCO2)c1
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
